COVID-19 Transforms the Clinical Trial Industry Ecosystem | IndustryWired

Anju Software’s Chief Innovation Officer Suhas Gudihal and Executive Vice President Mike Keens are featured in IndustryWired. The piece reflects on COVID’s disruptive effect on clinical trial initiations during the pandemic’s early stages and explores the pivotal role that innovative digital technology platforms have subsequently played in transforming and improving the industry.

Chief Innovation Officer; Co-Founder, Anju Software
Suhas Gudihal, Chief Innovation Officer, Co-Founder, Anju Software

Executive VP Operations, Anju Software
Mike Keens, Executive VP Operations, Anju Software

Anju Software
Anju Software provides robust digital technology platforms such as TrialMaster to enable cutting-edge decentralized, digital and synthetic clinical trials.

Want to stay up to date with our news?

To top